Given the number of holders that are in the process of sell and buy back via Rights Issue I suspect they will get the min. + maybe even something close to the $6M.
Consider this:
Suda as at 31/12/2012
Shares on issue circa: 610,000,000
Share Price: 3.3c
Market Cap: $20.13M
Debt on balance sheet $700,000
HCBP Liability Status: Known and in process of defending the action
Product Pipeline
- ArtiMist in Stage 3 Trials
-Intention to acquire assets of Novel known
Market Cap: $20.13M
----------------------------------------------------------------------------------------------------------
Suda as at 13/07/2018
Share on issue circa: 1.2B
Likely Share Price: 0.5c
Market Cap: $6M
Debt on balance sheet $2M (will be $0 at 31/07/20-18 if CR >$4M as anticipated)
HCBP Liability Status: Resolved with payment plan - $2.5M over 3.5 years
Product Pipeline
- ArtiMist Pending TGA Approval expected end of CY2018
- ZolpiMist Global rights excl. North America. Deals with EddingPharm and Teva
- SUD-001 Advanced Negations to license to Pharma Co in USA
- SUD-003 Deal discussions ongoing
- SUD-004 Discussing development options with potential partners
- SUD-005 In discussions with multiple potential partners to enter global license agreement
-SUD-018 Lab work, potential significant market for product IF proven
-Pfizer OTC still pending decision from Pfizer
Also Teva expect to have marketing approval during Q2 FY19 for Chile which will trigger milestone payment to Suda. Royalties on sales to follow per agreement.
Market Cap: $6M
I believe all of the above is correct. I'm $^ at this situation however do think they will get the $4M min. Also getting Teva Chile ZopliMist registered and receiving payment is out of Suda's hands, if they do basically nothing $ will still be heading their way...
- Forums
- ASX - By Stock
- ALA
- SELL & take
SELL & take, page-22
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALA (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.5¢ |
Change
0.010(6.45%) |
Mkt cap ! $173.5M |
Open | High | Low | Value | Volume |
15.5¢ | 16.5¢ | 15.5¢ | $298.5K | 1.873M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 167374 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 510665 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.160 |
8 | 289575 | 0.155 |
13 | 656525 | 0.150 |
9 | 270205 | 0.145 |
7 | 234046 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 763907 | 11 |
0.170 | 1061841 | 13 |
0.175 | 905855 | 9 |
0.180 | 1194230 | 8 |
0.185 | 47421 | 5 |
Last trade - 14.07pm 01/10/2024 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online